MicroRNAs and immunotherapy in testicular germ cell tumors: opportunities and challenges for modulation of the immune microenvironment - Takeaways - MDSpire

MicroRNAs and immunotherapy in testicular germ cell tumors: opportunities and challenges for modulation of the immune microenvironment

  • By

  • Alejandro Lopez-Saavedra

  • José Díaz-Chávez

  • Miguel Angel Jimenez-Ríos

  • Anna Scavuzzo

  • June 11, 2026

  • 0 min

Share

  • 1

    Testicular germ cell tumors (TGCTs) are the most common solid malignancies in young men, often leading to treatment-resistant disease.

  • 2

    Despite high cure rates with cisplatin-based therapy, a subset of TGCT patients experiences relapsed or refractory disease with limited options.

  • 3

    Immunotherapy has shown disappointing results in TGCT, despite the presence of immune checkpoint molecules and tumor-infiltrating lymphocytes.

  • 4

    MicroRNAs (miRNAs) are emerging as key regulators of immune escape and may influence the efficacy of immunotherapy in TGCT.

  • 5

    The review suggests a need for mechanism-based strategies integrating miRNAs with immunotherapy to improve treatment outcomes in TGCT.

Original Source(s)

MicroRNAs and immunotherapy in testicular germ cell tumors: opportunities and challenges for modulation of the immune microenvironment

  • by Alejandro Lopez-Saavedra, José Díaz-Chávez, Miguel Angel Jimenez-Ríos, Anna Scavuzzo

  • June 11, 2026

Related Content

Combination of metformin and parthenolide inhibits breast cancer in mice by apoptosis induction and angiogenesis inhibition

Clinical utility of an optoelectronic imaging tracing system for diagnosis of high-grade cervical lesions

Case Report: Fatal pneumonitis caused by Camrelizumab and Erlotinib in a patient with metastatic pancreatic cancer